Welcome to our dedicated page for National Resh SEC filings (Ticker: NRC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Investors researching National Research Corp (NRC) usually start with one question: how do patient-experience surveys turn into industry-leading recurring revenue? If you have ever typed “Where can I find National Research Corp’s quarterly earnings report 10-Q filing” or searched for “National Research Corp insider trading Form 4 transactions,” this page is built for you. We organise every 10-K, 10-Q, 8-K and proxy statement so you can spot renewal rates, new hospital contracts and changes in subscription backlog without wading through hundreds of pages.
Stock Titan layers AI on top of the raw EDGAR feed. Our models translate accounting language into plain English, flag revenue concentration risks, and answer natural prompts such as “understanding National Research Corp SEC documents with AI” within seconds. Receive alerts the moment a National Research Corp Form 4 insider transactions real-time filing arrives, then review a concise summary that highlights which executive bought or sold shares. Need the big picture? Our AI-powered summaries distill the annual report—search “National Research Corp annual report 10-K simplified” and jump straight to patient-engagement metrics, segment margins and cash-flow trends.
All major filing types are covered in one place:
- Form 4 updates for “National Research Corp executive stock transactions Form 4”
- 8-K briefs so “National Research Corp 8-K material events explained” is more than a headline
- Detailed proxy reviews answering “National Research Corp proxy statement executive compensation”
- Quarterly insight packs for every “National Research Corp earnings report filing analysis”
National Research Corporation appointed Shane Harrison as Executive Vice President and Chief Financial Officer effective on or about September 25, 2025. On that date Harrison will become the company's principal financial officer and Michael D. Hays will cease serving in that role. The Talent and Compensation Committee approved an annualized base salary of $400,000, a $100,000 cash signing bonus (subject to pro-rated return if Harrison departs before the first anniversary except for certain terminations), and a grant of 172,000 restricted shares that vest 25% after 90 days and 25% on each of the first three anniversaries thereafter. The equity award includes double-trigger vesting on a change in control plus a holding requirement to retain shares until their value equals at least two times his annual base salary. If terminated without cause or resigning for good reason, Harrison is entitled to one year of continued base salary. The filing states no related-party arrangements and includes a press release exhibit announcing the appointment.
National Research Corporation (NRC) Q2-25 10-Q highlights
- Revenue: Q2-25 fell 3% YoY to $34.0 m; 1H-25 down 4% to $67.6 m as subscription services (92% of total) softened.
- Profitability: Q2 operating income collapsed 82% to $1.6 m and the company posted a net loss of $0.1 m (-$0.01 EPS) versus $6.2 m profit a year ago, driven by $6.6 m one-time CEO & executive cash bonuses and higher stock-based comp. Operating margin shrank to 5% (25% prior year). 1H-25 net income was $5.7 m ($0.25 EPS), down 55%.
- Cash & leverage: Cash rose to $5.3 m (from $4.2 m), but operating cash flow plunged 71% to $5.5 m. Debt jumped to $81.4 m (vs. $48.5 m) after drawing on a new delayed-draw term loan; net leverage now 3.8× EBITDA (company must stay ≤3.5×).
- Equity & buybacks: Treasury share repurchases of $10.9 m plus the Q2 loss cut shareholders’ equity to $21.3 m (-32% YTD). 700 k restricted shares issued under new 2025 Omnibus Plan.
- Contract metrics: Total Recurring Contract Value (TRCV) declined 1% YoY to $137 m but improved sequentially for two quarters; retention rate +2 ppts.
- Tax impact: Effective tax rate spiked to 118% due to non-deductible executive pay.
- Leadership: Trent Green appointed CEO 1 Jun 25; former CEO became Chairman.
Management expects margins to recover once executive compensation normalizes but flagged higher interest expense as debt increases.
FAQ
What is the current stock price of National Resh (NRC)?
What is the market cap of National Resh (NRC)?
